PROCESSA PHARMACEUTICALS INC (PCSA)

US74275C3043 - Common Stock

2.09  -0.04 (-1.88%)

After market: 2.09 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
11.46M20.26M11.57M6.44M3.94M
Research and Development
5.80M10.71M6.09M2.38M1.53M
Selling, General, and Administrative Expenses
5.66M8.76M4.69M3.26M1.61M
Operating Income
-11.46M-20.26M-11.57M-6.44M-3.94M
Interest Income/Expense
335.54K100.00K10.00K-280.00K-30.00K
Non Recurring Items
0.00-7.27M-400.00K-8.70MN/A
Income Before Taxes
-11.12M-27.42M-11.96M-15.41M-3.96M
Income Tax
0.000.00-530.00K-1.00M-600.00K
Net Income
-11.12M-27.42M-11.43M-19.04M-3.86M
EBITDA
-11.46M-19.47M-10.78M-5.63M-3.13M
 
Per Share Data
EPS Diluted Total Ops
-8.48-1.70-0.75-2.54-0.70
Non GAAP EPS
N/A-8.09-0.74N/AN/A
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
N/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts